Green Cross Corporation (006280.KS)
KRW 168000.0
(-1.7%)
KRW 168000.0
(-1.7%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 674.31 Billion KRW | 43.42% |
| 2022 | 470.17 Billion KRW | 11.81% |
| 2021 | 420.51 Billion KRW | 25.85% |
| 2020 | 334.14 Billion KRW | -13.15% |
| 2019 | 384.71 Billion KRW | 65.73% |
| 2018 | 232.13 Billion KRW | 63.47% |
| 2017 | 142 Billion KRW | -26.01% |
| 2016 | 191.92 Billion KRW | 156.07% |
| 2015 | 74.94 Billion KRW | -41.66% |
| 2014 | 128.47 Billion KRW | 522.24% |
| 2013 | 20.64 Billion KRW | -65.25% |
| 2012 | 59.41 Billion KRW | 990.65% |
| 2011 | 5.44 Billion KRW | -84.46% |
| 2010 | 35.05 Billion KRW | -65.89% |
| 2009 | 102.77 Billion KRW | -37.25% |
| 2008 | 163.8 Billion KRW | 140.35% |
| 2007 | 68.15 Billion KRW | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 826.07 Billion KRW | 8.9% |
| 2024 Q1 | 758.54 Billion KRW | 12.49% |
| 2023 Q2 | 613.35 Billion KRW | 10.42% |
| 2023 Q4 | 674.31 Billion KRW | -3.82% |
| 2023 Q3 | 701.06 Billion KRW | 14.3% |
| 2023 FY | 674.31 Billion KRW | 43.42% |
| 2023 Q1 | 555.46 Billion KRW | 18.14% |
| 2022 FY | 763.68 Billion KRW | 11.81% |
| 2022 Q4 | 470.17 Billion KRW | -4.5% |
| 2022 Q3 | 492.34 Billion KRW | 2.49% |
| 2022 Q2 | 480.39 Billion KRW | 21.49% |
| 2022 Q1 | 395.43 Billion KRW | -5.96% |
| 2021 Q2 | 441.66 Billion KRW | 17.37% |
| 2021 Q1 | 376.3 Billion KRW | 12.62% |
| 2021 Q4 | 420.51 Billion KRW | -5.77% |
| 2021 FY | 592.42 Billion KRW | 25.85% |
| 2021 Q3 | 446.25 Billion KRW | 1.04% |
| 2020 Q4 | 334.14 Billion KRW | -24.53% |
| 2020 FY | 509.91 Billion KRW | -13.15% |
| 2020 Q1 | 456.99 Billion KRW | 18.79% |
| 2020 Q2 | 458.86 Billion KRW | 0.41% |
| 2020 Q3 | 442.76 Billion KRW | -3.51% |
| 2019 Q4 | 384.71 Billion KRW | 5.26% |
| 2019 Q3 | 365.49 Billion KRW | 11.5% |
| 2019 Q1 | 309.11 Billion KRW | 33.16% |
| 2019 Q2 | 327.79 Billion KRW | 6.05% |
| 2019 FY | 678.92 Billion KRW | 65.73% |
| 2018 Q4 | 232.13 Billion KRW | -6.08% |
| 2018 Q3 | 247.15 Billion KRW | 7.15% |
| 2018 FY | 541.67 Billion KRW | 63.47% |
| 2018 Q1 | 187.1 Billion KRW | 31.76% |
| 2018 Q2 | 230.65 Billion KRW | 23.28% |
| 2017 Q4 | 142 Billion KRW | -18.4% |
| 2017 Q3 | 174.02 Billion KRW | 16.28% |
| 2017 FY | 422.79 Billion KRW | -26.01% |
| 2017 Q1 | 150.19 Billion KRW | -21.74% |
| 2017 Q2 | 149.65 Billion KRW | -0.36% |
| 2016 Q3 | 101.06 Billion KRW | 1.87% |
| 2016 FY | 377.44 Billion KRW | 156.07% |
| 2016 Q4 | 191.92 Billion KRW | 89.9% |
| 2016 Q1 | 207.95 Billion KRW | 177.46% |
| 2016 Q2 | 99.21 Billion KRW | -52.29% |
| 2015 Q1 | 197.56 Billion KRW | 53.77% |
| 2015 Q3 | 114.27 Billion KRW | -48.88% |
| 2015 Q4 | 74.94 Billion KRW | -34.41% |
| 2015 Q2 | 223.55 Billion KRW | 13.16% |
| 2015 FY | 174.75 Billion KRW | -41.66% |
| 2014 Q4 | 128.47 Billion KRW | -10.99% |
| 2014 Q3 | 144.33 Billion KRW | 28.63% |
| 2014 FY | 207.38 Billion KRW | 522.24% |
| 2014 Q1 | 86.18 Billion KRW | 317.39% |
| 2014 Q2 | 112.2 Billion KRW | 30.2% |
| 2013 Q3 | 20.88 Billion KRW | 15.47% |
| 2013 FY | 157.37 Billion KRW | -65.25% |
| 2013 Q1 | -27.61 Billion KRW | -146.48% |
| 2013 Q2 | 18.09 Billion KRW | 165.51% |
| 2013 Q4 | 20.64 Billion KRW | -1.16% |
| 2012 Q2 | 27.01 Billion KRW | 135.03% |
| 2012 Q1 | 11.49 Billion KRW | 111.04% |
| 2012 FY | 133.28 Billion KRW | 990.65% |
| 2012 Q4 | 59.41 Billion KRW | -12.86% |
| 2012 Q3 | 68.18 Billion KRW | 152.35% |
| 2011 FY | 300.88 Billion KRW | -84.46% |
| 2011 Q4 | 5.44 Billion KRW | -87.75% |
| 2011 Q3 | 44.46 Billion KRW | 50.66% |
| 2011 Q2 | 29.51 Billion KRW | -54.01% |
| 2011 Q1 | 64.17 Billion KRW | 0.0% |
| 2010 Q1 | 97 Billion KRW | -5.62% |
| 2010 Q3 | 75.7 Billion KRW | -8.53% |
| 2010 FY | -26.12 Billion KRW | -65.89% |
| 2010 Q2 | 82.76 Billion KRW | -14.68% |
| 2009 Q1 | 189.72 Billion KRW | 15.82% |
| 2009 Q3 | 164.12 Billion KRW | -3.22% |
| 2009 Q2 | 169.58 Billion KRW | -10.62% |
| 2009 Q4 | 102.77 Billion KRW | -37.38% |
| 2009 FY | 63.52 Billion KRW | -37.25% |
| 2008 Q1 | 100.79 Billion KRW | 47.9% |
| 2008 Q4 | 163.8 Billion KRW | 20.81% |
| 2008 Q3 | 135.58 Billion KRW | 26.62% |
| 2008 Q2 | 107.07 Billion KRW | 6.24% |
| 2008 FY | 191.3 Billion KRW | 140.35% |
| 2007 FY | 66.32 Billion KRW | 0.0% |
| 2007 Q4 | 68.15 Billion KRW | 4.19% |
| 2007 Q1 | 49.49 Billion KRW | 0.0% |
| 2007 Q2 | 65.63 Billion KRW | 32.59% |
| 2007 Q3 | 65.41 Billion KRW | -0.34% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ORIENT BIO Inc. | -3.06 Billion KRW | 22070.162% |
| Green Cross Holdings Corporation | 1105.62 Billion KRW | 39.011% |
| Green Cross Holdings Corporation | 674.31 Billion KRW | 0.0% |
| Pharmicell Co., Ltd. | -10.69 Billion KRW | 6404.167% |
| GeneOne Life Science, Inc. | 8.04 Billion KRW | -8277.875% |
| Celltrion, Inc. | 1325.8 Billion KRW | 49.139% |
| Samsung Biologics Co.,Ltd. | 1541.39 Billion KRW | 56.253% |
| SK bioscience Co.,Ltd. | -106.45 Billion KRW | 733.445% |
| SK Biopharmaceuticals Co., Ltd. | -61.64 Billion KRW | 1193.781% |
| Prestige BioPharma Limited | -129.76 Billion KRW | 619.639% |